BMS Archive

Fungi · Scientific monograph

Polyporus umbellatus

Zhu Ling / Umbrella Polypore

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Immunological Research, Renal & Fluid Regulation Research, Cellular & Immune Studies

Research overview

Historical use

Known in TCM as 'Zhu Ling', used for over 2,000 years primarily as a diuretic and for treating oedema, urinary difficulty, and diarrhoea. Referenced in classical texts including Shen Nong Ben Cao Jing. The sclerotium grows on the roots of deciduous trees. A major component of the classical TCM formula 'Zhu Ling Tang' for urinary tract disorders.

Modern research context

Ergone and polysaccharides (PU-PS) are the primary bioactives; phytochemistry, pharmacology, and pharmacokinetics have been comprehensively reviewed [3][2]. Zhu Ling polysaccharide injection (ZPS) is used in China as an adjunct in cancer management, with evidence of efficacy demonstrated for hepatitis B [1]. Diuretic effects are well-documented in the pharmacological literature. Renoprotective polysaccharide activity has been demonstrated in preclinical models [4]. Immunomodulatory nanocomposites derived from PU polysaccharides are under investigation for enhanced anti-tumour activity [5].

Adverse effects

Generally well tolerated. Electrolyte imbalance possible with prolonged high-dose use due to diuretic effect. Rare GI symptoms.

Contraindications

Diuretics — additive electrolyte-depleting effect. Antihypertensives — additive hypotensive effect. Lithium — diuretic-mediated lithium retention.

Clinical and phytochemical data

Used part

Sclerotium and fruiting body

Primary active compounds

  • Polyporus umbellatus polysaccharides (PU-PS, beta-glucan)

  • Ergone (ergosta-4,6,8(14),22-tetraen-3-one)

  • Acetosyringone

  • Biotin

Mechanism of action

PU-PS activates macrophages and T-cells via TLR-2/Dectin-1; stimulates IL-2, IFN-γ. Anti-tumour effects via NK cell activation and induction of tumour cell apoptosis (Bcl-2 suppression). Diuretic mechanism: inhibition of renal Na⁺/K⁺-ATPase and modulation of aquaporin expression. Ergosterol is a precursor to vitamin D2.

Pharmacokinetics

Absorption

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Limited human PK data. Polysaccharides have limited systemic oral bioavailability. Ergone absorption profile not characterised in humans.

Distribution

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Polysaccharide fractions (PU-PS) concentrate in kidneys, spleen, and lymph nodes, consistent with diuretic and immunomodulatory effects. Ergosterol derivatives distribute systemically. No formal human pharmacokinetic distribution studies available.

Metabolism

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Assumed hepatic metabolism of steroid (ergone) compounds. Polysaccharides fermented in colon.

Excretion

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Renal excretion (diuretic mechanism increases urinary output). Fecal for unabsorbed polysaccharides.

Safety and interactions

Drug interactions

Lack of clinical studies prevents interaction grading. Unknown safety profile with concomitant drug use.

Toxicity

LD50 >5 g/kg (oral, rodents). No significant organ toxicity in animal studies. Human clinical data limited; ZPS injection well-tolerated in cancer adjunct trials.

Special precautions

Pregnancy

Insufficient clinical data. Diuretic properties could theoretically affect fluid balance. Avoid during pregnancy.

Lactation

No data available. Avoid during breastfeeding.

Hepatic impairment

No hepatotoxicity documented. Standard monitoring recommended.

Renal impairment

Diuretic properties require caution in renal impairment; monitor electrolytes and renal function.

Sources and references

  1. [1] - Guo Z., "The efficacy of Polyporus Umbellatus polysaccharide in treating hepatitis B in China.", Prog Mol Biol Transl Sci, 2019, PMID: 31030753
  2. [2] - He D., "Phytochemistry and bioactivities of the main constituents of Polyporus umbellatus (Pers.) Fr.", Phytomedicine, 2022, PMID: 35667259
  3. [3] - Zhao YY., "Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus.", J Ethnopharmacol, 2013, PMID: 23811047
  4. [4] - Li H., "Renoprotective effect and mechanism of polysaccharide from Polyporus umbellatus sclerotia.", Carbohydr Polym, 2019, PMID: 30832835
  5. [5] - Liu T., "Polyporus umbellatus polysaccharide iron-based nanocomposite for synergistic M1 polarization and tumor cell death.", Int J Biol Macromol, 2023, PMID: 37586629

Additional source links

Continue browsing